Ontology highlight
ABSTRACT: Objective
There are unique challenges to designing and carrying out high-quality trials testing therapeutic devices in OA and other rheumatic diseases. Such challenges include determining the mechanisms of action of the device and the appropriate sham. Design of device trials is more challenging than that of placebo-controlled drug trials. Our aim was to develop recommendations for designing device trials.Methods
An Arthritis Research UK study group comprised of 30 rheumatologists, physiotherapists, podiatrists, engineers, orthopaedists, trialists and patients, including many who have carried out device trials, met and (using a Delphi-styled approach) came to consensus on recommendations for device trials.Results
Challenges unique to device trials include defining t
SUBMITTER: Felson DT
PROVIDER: S-EPMC5854040 | biostudies-literature | 2016 Feb
REPOSITORIES: biostudies-literature